These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36813176)
1. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT? Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685 [TBL] [Abstract][Full Text] [Related]
3. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD; Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990 [TBL] [Abstract][Full Text] [Related]
4. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863 [TBL] [Abstract][Full Text] [Related]
5. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial. Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124 [TBL] [Abstract][Full Text] [Related]
6. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846 [TBL] [Abstract][Full Text] [Related]
7. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer. Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795 [TBL] [Abstract][Full Text] [Related]
8. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Barbon CEA; Yao CMK; Peterson CB; Moreno AC; Goepfert RP; Johnson FM; Chronowski GM; Fuller CD; Gross ND; Hutcheson KA Otolaryngol Head Neck Surg; 2022 Sep; 167(3):484-493. PubMed ID: 34784256 [TBL] [Abstract][Full Text] [Related]
9. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy. Scott SI; Madsen AKØ; Rubek N; Charabi BW; Wessel I; Jensen CV; Friborg J; von Buchwald C Laryngoscope; 2023 Aug; 133(8):1893-1898. PubMed ID: 36239625 [TBL] [Abstract][Full Text] [Related]
10. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial. Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246 [TBL] [Abstract][Full Text] [Related]
11. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Gupta KK; De M; Athanasiou T; Georgalas C; Garas G Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678 [TBL] [Abstract][Full Text] [Related]
12. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study. Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703 [TBL] [Abstract][Full Text] [Related]
13. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy. Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323 [TBL] [Abstract][Full Text] [Related]
14. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer. Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238 [TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
16. Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study. Staibano P; Au M; Xie M; Gupta MK; Young JEMT; Zhang H Oral Oncol; 2024 Dec; 159():107033. PubMed ID: 39278148 [TBL] [Abstract][Full Text] [Related]
17. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management. Dawe N; Patterson J; O'Hara J Clin Otolaryngol; 2016 Aug; 41(4):371-85. PubMed ID: 26292983 [TBL] [Abstract][Full Text] [Related]
18. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma. Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211 [TBL] [Abstract][Full Text] [Related]
19. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma]. Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232 [No Abstract] [Full Text] [Related]
20. Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial. O'Hara JT; Hurt CN; Ingarfield K; Patterson JM; Hutcheson K; Canham JE; Nixon LS; Heiberg CD; Johson S; Evans M; Jones TM JAMA Otolaryngol Head Neck Surg; 2024 Oct; 150(11):1002-11. PubMed ID: 39388196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]